Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/europace/euv088 | DOI Listing |
Hosp Pharm
November 2024
Department of Clinical and Pharmacy Practice, Universiti Teknologi MARA, Kampus Puncak Alam, Cawangan Selangor, Malaysia.
In Asian countries, warfarin is still widely used for stroke prevention in non-valvular atrial fibrillation compared to non-vitamin K antagonist oral anticoagulants (NOACs) due to its affordability. A tool such as the SAMe-TTR is needed to determine the probability of achieving and maintaining good anticoagulation control with warfarin therapy. However, it requires validation in the Malaysian cohort.
View Article and Find Full Text PDFAnn Indian Acad Neurol
February 2024
Department of Cardiology, Ataturk Research and Training Hospital, Izmir Katip Çelebi University, Izmir/Turkey.
Background: Atrial fibrillation (AF) is the main arrhythmia associated with thromboembolic complications and cognitive impairment. In this study, we aimed to evaluate the relationship between cognitive impairment and different scoring systems developed for AF to improve the medical follow-up of cognitive impairment.
Methods: Between January 2019 and December 2020, 124 patients between the age of 30 and 80 years, diagnosed with AF for at least 5 years and complaining about memory impairment during cardiological follow-up, were included in the study.
Korean J Intern Med
May 2024
Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea.
Background/aims: The SAMe-TT2R2 score is used for assessing anticoagulation control (AC) quality with warfarin. However, it is hard to apply SAMe-TT2R2 score in Asian patients with atrial fibrillation (AF), because it has not been proven in those populations. This study aimed to validate the SAMe-TT2R2 score in Asian patients with AF and suggest a modified SAMe- TT2R2 score for this population.
View Article and Find Full Text PDFAnn Pharmacother
February 2024
Department of Pharmaceutical Care, School of Pharmacy, Walailak University, Nakhon Si Thammarat, Thailand.
Background: The SAMe-TTR score identifies patients on vitamin K antagonists (VKAs) who are more likely to have poor time in therapeutic range (TTR); however, the association between SAMe-TTR and clinical outcomes remains controversial.
Objectives: The objective is to assess the association of SAMe-TTR score with clinical outcomes and poor TTR in patients on VKAs.
Methods: We searched using the term "SAMe-TTR.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!